Similar articles

• Immune complexes in myasthenia gravis.

  Behan WM, Behan PO. Behan WM, et al. J Neurol Neurosurg Psychiatry. 1979 Jul;42(7):595-9. doi: 10.1136/jnnp.42.7.595. J Neurol Neurosurg Psychiatry. 1979. PMID: 479898 Free PMC article.
• Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.

  Santoro F, Bout D, Camus D, Capron A. Santoro F, et al. Rev Inst Med Trop Sao Paulo. 1977 Jan-Feb;19(1):39-42. Rev Inst Med Trop Sao Paulo. 1977. PMID: 897474 No abstract available.
• Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.

  Tüzün E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P. Tüzün E, et al. Neuromuscul Disord. 2006 Feb;16(2):137-43. doi: 10.1016/j.nmd.2005.11.005. Epub 2006 Jan 19. Neuromuscul Disord. 2006. PMID: 16427283
• Incidence and clinical significance of circulating immune complexes in glomerulonephritis.

  Valentijn RM, Daha MR, Van Es LA. Valentijn RM, et al. Neth J Med. 1984;27(9):340-9. Neth J Med. 1984. PMID: 6392910 Review. No abstract available.
• Immune deposits in human aortic atherosclerotic wall.

  Vlaicu R, Niculescu F, Rus HG, Cristea A. Vlaicu R, et al. Med Interne. 1983 Jan-Mar;21(1):3-8. Med Interne. 1983. PMID: 6342110 Review. No abstract available.